In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Express Scripts Holding Co.

Division of Cigna Corp.
www.express-scripts.com

Latest From Express Scripts Holding Co.

Rx Pricing, Rebating Should Be Back To Business As Usual In 2020, PBMs Say

Political focus of drug pricing debate has shifted away from pharmacy benefit managers, CVS Health’s Merlo suggests.

Pricing Debate Reimbursement

Teva Seeks Global Resolution Of Opioid Litigation

Teva and three distributors settle with two plaintiffs; PBMs are defendants in next case as Teva also reaches an agreement in principal with four attorneys general for global settlement framework.

Legal Issues Strategy

Teva Seeks Global Resolution Of Opioid Litigation As Bellwether Trial Is Halted

Teva and three distributors settle with two plaintiffs; PBMs are defendants in next case as Teva also reaches an agreement in principal with four attorneys general for global settlement framework. 

Legal Issues Advertising, Marketing & Sales

Progress Being Made With Cell And Gene Therapy Market Access, But Challenges Remain

Drug developers and payers are coming together long before product approvals to work out payment options for high-cost, high-impact cell and gene therapies, but challenges like portability of commercially insured patients and Medicaid best price requirements remain.

Reimbursement Market Access
See All

Company Information

UsernamePublicRestriction

Register